Nuclear factor κb-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity

Journal of Experimental Medicine

Volumn 196, Issue 5, 2002, Pages 605-617

  Hinz, Michael ^a   Lemke, Petra ^a   Anagnostopoulos, Ioannis ^b   Hacker, Christine ^a   Krappmann, Daniel ^a   Mathas, Stephan ^a,c   Dörken, Bernd ^a,c   Zenke, Martin ^a   Stein, Harald ^b   Scheidereit, Claus ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Section of Pathology   (Germany)

Author keywords

Chromatin; Microarray; Oncogene; Survival; Tumor suppressor

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; RECEPTOR; STAT5 PROTEIN; TRANSCRIPTION FACTOR; DNA; DNA BINDING PROTEIN; MESSENGER RNA; MILK PROTEIN; RNA; STAT5A PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; REED STERNBERG CELL; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; CELL CULTURE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY;

BASE SEQUENCE; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; HODGKIN DISEASE; HUMANS; MILK PROTEINS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); REED-STERNBERG CELLS; RNA, MESSENGER; RNA, NEOPLASM; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0036707512     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020062     Document Type: Article

References (79)

1. NF-κB: Ten years after
2. The NF-κB and IκB proteins: New discoveries and insights
3. Genetic approaches in mice to understand Rel/NF-κB and IκB function: Transgenics and knockouts
4. Rel/NF-κB transcription factors and the control of apoptosis
5. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
6. Control of apoptosis by Rel/NF-κB transcription factors
7. Aberrant rel/nfkb genes and activity in human cancer
8. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
9. New insights into the role of nuclear factor-κB in cell growth regulation
10. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
11. Epstein-barr virus transformation: Involvement of latent membrane protein 1-mediated activation of NF-κB
12. Persistent activation of NF-κB by the tax transforming protein of HTLV-1: Hijacking cellular IκB kinases
13. A requirement for NF-κB activation in Bcr-Abl-mediated transformation
14. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-κB pathway
15. High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
16. The nature of Reed-Sternberg cells: Phenotype, genotype, and other properties
17. Hodgkin's disease
18. The molecular and cellular origins of Hodgkin's disease
19. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell
20. Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient
21. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
22. Overexpression of IκBα without inhibition of NF-κB activity and mutations in the IκBα gene in Reed-Sternberg cells
23. Mutations in the IκBα gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
24. Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma
25. Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
26. Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells
27. Two waves of nuclear factor κB recruitment to target promoters
28. Activators and target genes of Rel/NF-κB transcription factors
29. Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas
30. Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse
31. Lymphocyte-specific protein 1: A specific marker of human leucocytes
32. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells
33. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
34. NF-κB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1β, TNFα, and LPS
35. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells
36. Human T cell lymphotropic virus type I Tax activates IL-15Rα gene expression through an NF-κB site
37. Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs
38. A mechanism of suppression of TGFβ/SMAD signaling by NF-κB/RelA
39. Hodgkin's cells express CD83, a dendritic cell lineage associated antigen
40. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation
41. The inducible transcription activator NF-κB: Regulation by distinct protein subunits
42. Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice
43. STAT signaling in the pathogenesis and treatment of leukemias
44. Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas
45. High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease
46. Gene expression by single Reed-Sternberg cells: Pathways of apoptosis and activation
47. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells
48. Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease
49. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia
50. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils
51. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells
52. + T cells
53. The nature and action of granulocyte-macrophage colony stimulating factors
54. Biology of Hodgkin's disease
55. Involvement of chemokine receptors in breast cancer metastasis
56. Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells
57. CD40 and CD154 in cell-mediated immunity
58. Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma
59. Oncogenic alterations of metabolism
60. Expression of the fructose transporter GLUT5 in human breast cancer
61. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells
62. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation
63. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL
64. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2
65. Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors
66. Significance of CD44 gene products for cancer diagnosis and disease evaluation
67. Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines
68. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer
69. Placental protein 5 in benign and malignant ovarian cyst fluids
70. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon
71. Pathological roles of interleukin-15 in adult T-cell leukemia
72. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells
73. Regulation and function of adhesion molecules in B-cell chronic lymphocytic leukaemia
74. Biology and treatment of multiple myeloma
75. The role of adhesion molecules in multiple myeloma
76. Novel NEMO/IκB kinase and NF-κB target genes at the pre-B to immature B cell transition
77. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function
78. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300